RONNIE NEUBERG, MD
Pediatrics Physician · WEST COLUMBIA, SC
Individual Active NPI 1457328932
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 740 | 576,260.5 | $19,049,909 | $8,830,249 | $7,019,586 |
| 2023 | 549 | 360,636 | $20,156,032 | $9,873,530 | $7,855,696 |
| 2022 | 302 | 147,538 | $9,485,074 | $4,730,690 | $3,766,080 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 166,230 | $1 | $1 |
| J0485 | Injection, belatacept, 1 mg | 116,500 | $4 | $3 |
| J0897 | Injection, denosumab, 1 mg | 31,320 | $25 | $20 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 30,900 | $22 | $17 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 21,840 | $11 | $8 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 19,890 | $0 | $0 |
| J1306 | Injection, inclisiran, 1 mg | 17,040 | $12 | $9 |
| J2350 | Injection, ocrelizumab, 1 mg | 12,000 | $53 | $42 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 11,600 | $16 | $13 |
| J2357 | Injection, omalizumab, 5 mg | 9,615 | $35 | $28 |
| J3245 | Injection, tildrakizumab, 1 mg | 5,200 | $135 | $108 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,840 | $29 | $23 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Pediatrics Physician | 208000000X | ✓ | 12049 | SC |
| Pediatric Hematology & Oncology Physician | 2080P0207X | 12049 | SC |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Pediatrics Physician providers in South Carolina
- NPI 1780884700
- NPI 1124330139
- NPI 1700840030
- NPI 1417210279
- NPI 1194737122
- NPI 1578855805
- NPI 1003255605
- NPI 1265641419
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.